Search research articles
Contact Us
Filters
Showing results (11-20 of 16) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 16 results.
Virology
|
August 29, 1998
The EV-O-derived cell line DF-1 supports the efficient replication of avian leukosis-sarcoma viruses and vectors
J Schaefer-Klein, I Givol, E V Barsov, et al.
The EMBO Journal
|
March 17, 2001
Crystal structure of HIV-1 reverse transcriptase in complex with a polypurine tract RNA:DNA
S G Sarafianos, K Das, C Tantillo, et al.
JAMA
|
January 14, 2000
Drug susceptibility in HIV infection after viral rebound in patients receiving indinavir-containing regimens
D V Havlir, N S Hellmann, C J Petropoulos, et al.
Antimicrobial Agents and Chemotherapy
|
March 18, 2000
A novel phenotypic drug susceptibility assay for human immunodeficiency virus type 1
C J Petropoulos, N T Parkin, K L Limoli, et al.
Journal of Virology
|
October 24, 2000
Reduced susceptibility of human immunodeficiency virus type 1 (HIV-1) from patients with primary HIV infection to nonnucleoside reverse transcriptase inhibitors is associated with variation at novel amino acid sites
A J Brown, H M Precious, J M Whitcomb, et al.
JAMA
|
September 29, 1999
Reduced antiretroviral drug susceptibility among patients with primary HIV infection
S J Little, E S Daar, R T D'Aquila, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 16) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 16 results.
Virology
|
August 29, 1998
The EV-O-derived cell line DF-1 supports the efficient replication of avian leukosis-sarcoma viruses and vectors
J Schaefer-Klein, I Givol, E V Barsov, et al.
The EMBO Journal
|
March 17, 2001
Crystal structure of HIV-1 reverse transcriptase in complex with a polypurine tract RNA:DNA
S G Sarafianos, K Das, C Tantillo, et al.
JAMA
|
January 14, 2000
Drug susceptibility in HIV infection after viral rebound in patients receiving indinavir-containing regimens
D V Havlir, N S Hellmann, C J Petropoulos, et al.
Antimicrobial Agents and Chemotherapy
|
March 18, 2000
A novel phenotypic drug susceptibility assay for human immunodeficiency virus type 1
C J Petropoulos, N T Parkin, K L Limoli, et al.
Journal of Virology
|
October 24, 2000
Reduced susceptibility of human immunodeficiency virus type 1 (HIV-1) from patients with primary HIV infection to nonnucleoside reverse transcriptase inhibitors is associated with variation at novel amino acid sites
A J Brown, H M Precious, J M Whitcomb, et al.
JAMA
|
September 29, 1999
Reduced antiretroviral drug susceptibility among patients with primary HIV infection
S J Little, E S Daar, R T D'Aquila, et al.
Page
of 2